BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25350400)

  • 1. Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.
    Clarke RH; Moosa S; Anzivino M; Wang Y; Floyd DH; Purow BW; Lee KS
    PLoS One; 2014; 9(10):e111199. PubMed ID: 25350400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
    Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
    Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
    Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
    Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p/miR-130b-3p/PTEN/HIF-1α pathway.
    Xie T; Ding YH; Sang CS; Lin ZX; Dong J; Fu XA
    Strahlenther Onkol; 2024 Jun; 200(6):535-543. PubMed ID: 38453699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effects of simulated hypoxia by CoCl
    Khakshour E; Bahreyni-Toossi MT; Anvari K; Shahram MA; Vaziri-Nezamdoust F; Azimian H
    Mutat Res; 2024; 828():111848. PubMed ID: 38154290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.
    Marampon F; Gravina GL; Zani BM; Popov VM; Fratticci A; Cerasani M; Di Genova D; Mancini M; Ciccarelli C; Ficorella C; Di Cesare E; Festuccia C
    Int J Oncol; 2014 Jun; 44(6):2121-31. PubMed ID: 24676782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells.
    Liu Z; Tan H; Zhang X; Chen F; Zhou Z; Hu X; Chang S; Liu P; Zhang H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S922-S930. PubMed ID: 30307330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.
    Yong Y; Zhang C; Gu Z; Du J; Guo Z; Dong X; Xie J; Zhang G; Liu X; Zhao Y
    ACS Nano; 2017 Jul; 11(7):7164-7176. PubMed ID: 28640996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
    Sheehan J; Cifarelli CP; Dassoulas K; Olson C; Rainey J; Han S
    J Neurosurg; 2010 Aug; 113(2):234-9. PubMed ID: 20001586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas.
    Mudassar F; Shen H; O'Neill G; Hau E
    J Exp Clin Cancer Res; 2020 Oct; 39(1):208. PubMed ID: 33028364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme.
    Hsieh CH; Shyu WC; Chiang CY; Kuo JW; Shen WC; Liu RS
    PLoS One; 2011; 6(9):e23945. PubMed ID: 21935366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Williams JA; Dillehay LE; Tabassi K; Sipos E; Fahlman C; Brem H
    J Neurooncol; 1997 May; 32(3):181-92. PubMed ID: 9049879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions.
    Bache M; Zschornak MP; Passin S; Kessler J; Wichmann H; Kappler M; Paschke R; Kaluđerović GN; Kommera H; Taubert H; Vordermark D
    Radiat Oncol; 2011 Sep; 6():111. PubMed ID: 21906280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.
    Pinel S; Barberi-Heyob M; Cohen-Jonathan E; Merlin JL; Delmas C; Plenat F; Chastagner P
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):250-9. PubMed ID: 15093922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X; Dillehay LE; Williams JR; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma.
    Linnik IV; Scott ML; Holliday KF; Woodhouse N; Waterton JC; O'Connor JP; Barjat H; Liess C; Ulloa J; Young H; Dive C; Hodgkinson CL; Ward T; Roberts D; Mills SJ; Thompson G; Buonaccorsi GA; Cheung S; Jackson A; Naish JH; Parker GJ
    Magn Reson Med; 2014 May; 71(5):1854-62. PubMed ID: 23798369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
    Yang W; Wei J; Guo T; Shen Y; Liu F
    Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitexin, an inhibitor of hypoxia-inducible factor-1α, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma.
    Xie T; Wang JR; Dai CG; Fu XA; Dong J; Huang Q
    Clin Transl Oncol; 2020 Jul; 22(7):1086-1093. PubMed ID: 31677055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma.
    Miki S; Imamichi S; Fujimori H; Tomiyama A; Fujimoto K; Satomi K; Matsushita Y; Matsuzaki S; Takahashi M; Ishikawa E; Yamamoto T; Matsumura A; Mukasa A; Nishikawa R; Masutomi K; Narita Y; Masutani M; Ichimura K
    Cancer Sci; 2018 Jul; 109(7):2275-2285. PubMed ID: 29758120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption.
    Yasui H; Asanuma T; Kino J; Yamamori T; Meike S; Nagane M; Kubota N; Kuwabara M; Inanami O
    BMC Cancer; 2013 Mar; 13():106. PubMed ID: 23496909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.